SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adams, 2003, Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis, Biophys J, 85, 1548, 10.1016/S0006-3495(03)74587-1
Andersen, 2009, Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters, Chem Commun (Camb), 26, 3677, 10.1039/b903035m
Androutsellis-Theotokis, 2002, Accessibility and conformational coupling in serotonin transporter predicted internal domains, J Neurosci, 22, 8370, 10.1523/JNEUROSCI.22-19-08370.2002
Apparsundaram, 2001, Trafficking-dependent and independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells, J Pharmacol Exp Ther, 299, 666
Barker, 1996, Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter, Mol Pharmacol, 50, 957
Barker, 1994, Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands, Mol Pharmacol, 46, 799
Barker, 1999, Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter, J Neurosci, 19, 4705, 10.1523/JNEUROSCI.19-12-04705.1999
Batchelor, 1998, Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine, J Neurosci, 18, 10304, 10.1523/JNEUROSCI.18-24-10304.1998
Bauman, 2000, Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A, J Neurosci, 20, 7571, 10.1523/JNEUROSCI.20-20-07571.2000
Beckman, 1998, Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A, J Neurosci, 18, 6103, 10.1523/JNEUROSCI.18-16-06103.1998
Beckman, 1999, Multiple G protein-coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons, J Neurosci, 19, RC9, 10.1523/JNEUROSCI.19-11-j0006.1999
Blackstone, 2009, Infantile parkinsonism-dystonia: a dopamine “transportopathy”, J Clin Invest, 119, 1455
Borden, 1995, Cloning and expression of a betaine/GABA transporter from human brain, J Neurochem, 64, 977, 10.1046/j.1471-4159.1995.64030977.x
Borden, 1992, Molecular heterogeneity of the γ-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain, J Biol Chem, 267, 21098, 10.1016/S0021-9258(19)36802-4
Calati, 2011, The 5-HTTLPR polymorphism and eating disorders: a meta-analysis, Int J Eat Disord, 3, 191, 10.1002/eat.20811
Cao, 1998, Amino acid residues that control pH modulation of transport-associated current in mammalian serotonin transporters, J Neurosci, 18, 7739, 10.1523/JNEUROSCI.18-19-07739.1998
Carneiro, 2002, The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter, J Neurosci, 22, 7045, 10.1523/JNEUROSCI.22-16-07045.2002
Chen NH Reith ME (2002) Structure-function relationships for biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation, 2nd ed ( Reith ME ed) pp 53–109, Humana Press, Totowa, NJ.
de Paulis, 2007, Drug evaluation: Vilazodone–a combined SSRI and 5-HT1A partial agonist for the treatment of depression, IDrugs, 10, 193
Eshleman, 1999, Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type, J Pharmacol Exp Ther, 289, 877
Ferguson, 2001, The effects of antidepressants on sexual functioning in depressed patients, J Clin Psychiatry, 62, 22
Forlani, 2001, Three kinds of currents in the canine betaine-GABA transporter BGT-1 expressed in Xenopus laevis oocytes, Biochim Biophys Acta, 1538, 172, 10.1016/S0167-4889(00)00144-0
Fowler, 1999, PET and drug research and development, J Nucl Med, 40, 1154
Gadde, 2001, Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women, Obes Res, 9, 544, 10.1038/oby.2001.71
Galli, 1995, Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants, J Exp Biol, 198, 2197, 10.1242/jeb.198.10.2197
Giros, 1992, Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter, Mol Pharmacol, 42, 383
Gomeza, 1995, Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells, Biochim Biophys Acta, 1233, 41, 10.1016/0005-2736(94)00249-O
Gu, 1994, Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence, J Biol Chem, 269, 7124, 10.1016/S0021-9258(17)37256-3
Haenisch, 2008, Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes, Am J Med Genet B Neuropsychiatr Genet, 150B, 1013, 10.1002/ajmg.b.30912
Hahn, 2003, A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters, J Neurosci, 23, 4470, 10.1523/JNEUROSCI.23-11-04470.2003
Heffernan GD Coglan RD Manas ES McDevitt RE (2008) Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists I: synthesis and activity of novel 3-(phenylsulfonyl)-1H-indoles, in 236th American Chemical Society National Meeting; 17–21 Aug 2008; Philadelphia. American Chemical Society, Washington, DC.
Hellstrom, 2009, Emerging treatments for premature ejaculation: focus on dapoxetine, Neuropsychiatr Dis Treat, 5, 37
Humphreys, 1988, Antidepressant binding to the porcine and human-platelet serotonin transporters, Mol Pharmacol, 33, 657
Jursky, 1994, Structure, function and brain localization of neurotransmitter transporters, J Exp Biol, 196, 283, 10.1242/jeb.196.1.283
Kaiser C Setler PE (1981) Antipsychotic agents, in Burger's Medicinal Chemistry ( Wolff ME ed) pp 859–980, John Wiley & Sons, New York.
Kavanaugh, 1992, Electrogenic uptake of γ-aminobutyric acid by a cloned transporter expressed in Xenopus oocytes, J Biol Chem, 267, 22007, 10.1016/S0021-9258(18)41626-2
Keyes, 1982, Coupling of transmembrane proton gradients to platelet serotonin transport, J Biol Chem, 257, 1172, 10.1016/S0021-9258(19)68170-6
Kim, 1994, Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes, Mol Pharmacol, 45, 608
Kinney, 2003, The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior, J Neurosci, 23, 7586, 10.1523/JNEUROSCI.23-20-07586.2003
Kurian, 2009, Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia, J Clin Invest, 119, 1595
Labbate, 2003, Antidepressant-related erictile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation, J Clin Psychiatry, 64, 11
Lasky-Su, 2005, Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders, Am J Med Genet B Neuropsychiatr Genet, 133B, 110, 10.1002/ajmg.b.30104
Liu, 2003, Molecular characterization of four pharmacologically distinct α-aminobutyric acid transporters in mouse brain, J Biol Chem, 268, 2106, 10.1016/S0021-9258(18)53968-5
Liu, 1993, Cloning and expression of a spinal cord-specific and brain-specific glycine transporter with novel structural features, J Biol Chem, 268, 22802, 10.1016/S0021-9258(18)41598-0
Lopez-Corcuera, 1992, Expression of a mouse brain cDNA encoding novel γ-aminobutyric acid transporter, J Biol Chem, 267, 17491, 10.1016/S0021-9258(19)37067-X
Mager, 1996, Ion binding and permeation at the GABA transporter GAT1, J Neurosci, 16, 5405, 10.1523/JNEUROSCI.16-17-05405.1996
Massari, 2004, Protein kinase C-mediated phosphorylation of the BGT1 epithelial γ-aminobutyric acid transporter regulates its association with LIN7 PDZ proteins: a post-translational mechanism regulating transporter surface density, J Biol Chem, 280, 7388, 10.1074/jbc.M412668200
Melikian, 1999, Membrane trafficking regulates the activity of the human dopamine transporter, J Neurosci, 19, 7699, 10.1523/JNEUROSCI.19-18-07699.1999
Melikian, 1994, Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody, J Biol Chem, 269, 12290, 10.1016/S0021-9258(17)32714-X
Melikian, 1996, Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition, Mol Pharmacol, 50, 266
Melloni, 1984, Potential antidepressant agents: α-aryloxy-benzyl derivatives of ethanolamine and morpholine, Eur J Med Chem, 19, 235
Meyer, 2007, Imaging the serotonin transporter during major depressive disorder and antidepressant treatment, J Psychiatry Neurosci, 32, 86
Miller, 1994, Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP, J Biol Chem, 269, 27351, 10.1016/S0021-9258(18)46992-X
Morón, 2003, Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity, J Neurosci, 23, 8480, 10.1523/JNEUROSCI.23-24-08480.2003
Mortensen, 1999, Molecular cloning, expression and characterization of a bovine serotonin transporter, Mol Brain Res, 71, 120, 10.1016/S0169-328X(99)00178-3
Nelson, 1998, The family of Na+/Cl− neurotransmitter transporters, J Neurochem, 71, 1785, 10.1046/j.1471-4159.1998.71051785.x
Nirenberg, 1996, The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons, J Neurosci, 16, 436, 10.1523/JNEUROSCI.16-02-00436.1996
Norregaard, 2001, The monoamine neurotransmitter transporters: structure, conformational changes and molecular gating, Curr Opin Drug Discov Devel, 4, 591
O'Riordan, 1990, Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine, J Neurochem, 54, 1275, 10.1111/j.1471-4159.1990.tb01959.x
Oz, 2010, Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+, J Neurochem, 114, 1019, 10.1111/j.1471-4159.2010.06828.x
Paczkowski, 1999, Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters, J Pharmacol Exp Ther, 290, 761
Pantanowitz, 1993, Only one of the charged amino acids located in the transmembrane α-helices of the γ-aminobutyric acid transporter (subtype A) is essential for its activity, J Biol Chem, 268, 3222, 10.1016/S0021-9258(18)53681-4
Patel, 1993, Species differences in dopamine transporters: postmortem changes and glycosylation differences, J Neurochem, 61, 496, 10.1111/j.1471-4159.1993.tb02151.x
Pickel, 1999, Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens, J Neurosci, 19, 7356, 10.1523/JNEUROSCI.19-17-07356.1999
Pinard E Alberati D Borroni E Fischer H Hainzl D Jolidon S Moreau JL Narquizian R Nettekoven M Norcross R . (2010) Glycine transporter 1 inhibitors for the treatment of schizophrenia, in Frontiers in Medicinal Chemistry, Gesellschaft Deutscher Chemiker, Münster, Germany.
Plenge, 1985, Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes, Eur J Pharmacol, 119, 1, 10.1016/0014-2999(85)90314-0
Povlock SL Amara SG (1996) The structure and function of norepinephrine, dopamine and serotonin transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation ( Reith ME ed) pp 1–29, Humana Press, Totowa, NJ.
Prasad, 2001, The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage, J Neurosci, 21, 7561, 10.1523/JNEUROSCI.21-19-07561.2001
Qian, 1995, Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies, J Neurosci, 15, 1261, 10.1523/JNEUROSCI.15-02-01261.1995
Ramamoorthy S (2002) Regulation of monoamine transporters: regulated phosphorylation, dephosphorylation, and trafficking, in Neurotransmitter Transporters: Structure, Function, and Regulation, 2nd ed ( Reith ME ed) pp 1–23, Humana Press, Totowa, NJ.
Rudnick, 1993, From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters, Biochim Biophys Acta, 1144, 249, 10.1016/0005-2728(93)90109-S
Sakai, 1997, Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/threonine phosphatases, J Neurochem, 68, 2618, 10.1046/j.1471-4159.1997.68062618.x
Sato, 1995, Modulation of a recombinant glycine transporter (GLYT1b) by activation of protein kinase C, J Neurochem, 65, 1967, 10.1046/j.1471-4159.1995.65051967.x
Scholze, 2000, Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter, J Pharmacol Exp Ther, 293, 870
Segonzac, 1985, Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction, J Neurochem, 44, 349, 10.1111/j.1471-4159.1985.tb05423.x
Sesack, 1998, Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter, J Neurosci, 18, 2697, 10.1523/JNEUROSCI.18-07-02697.1998
Sette, 1983, Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers, J Neurochem, 40, 622, 10.1111/j.1471-4159.1983.tb08026.x
Sieghart, 1995, Structure and pharmacology of γ-aminobutyric acidA receptor subtypes, Pharmacol Rev, 47, 181
Sotnikova, 2006, Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter, CNS Neurol Disord Drug Targets, 5, 45, 10.2174/187152706784111579
Sulzer, 1995, Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport, J Neurosci, 15, 4102, 10.1523/JNEUROSCI.15-05-04102.1995
Sung, 2003, A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity, J Neurosci, 23, 1697, 10.1523/JNEUROSCI.23-05-01697.2003
Supplisson, 1997, Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes, J Neurosci, 17, 4580, 10.1523/JNEUROSCI.17-12-04580.1997
Talvenheimo, 1983, The serotonin transporter-imipramine “receptor.”, J Biol Chem, 258, 6115, 10.1016/S0021-9258(18)32380-9
Talvenheimo, 1979, Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport, J Biol Chem, 254, 4631, 10.1016/S0021-9258(17)30057-1
Tate, 1994, The effect of N-linked glycosylation on activity of the Na+- and Cl−-dependent serotonin transporter expressed using recombinant baculovirus in insect cells, J Biol Chem, 269, 26303, 10.1016/S0021-9258(18)47194-3
Wall, 1995, Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux, Mol Pharmacol, 47, 544
Whitworth, 2002, Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons, J Neurosci, 22, RC192, 10.1523/JNEUROSCI.22-01-j0003.2002
Wilbrandt, 1961, The concept of carrier transport and its corollaries in pharmacology, Pharmacol Rev, 13, 109
Wong, 1982, A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain, J Pharmacol Exp Ther, 222, 61
Wong, 2008, Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges, Curr Opin Investig Drugs, 9, 28
Yamauchi, 1992, Cloning of a Na+- and Cl−-dependent betaine transporter that is regulated by hypertonicity, J Biol Chem, 267, 649, 10.1016/S0021-9258(18)48543-2
Zafra, 1995, Glycine transporters are differentially expressed among CNS cells, J Neurosci, 15, 3952, 10.1523/JNEUROSCI.15-05-03952.1995